Supplementing Vitamin D in Different Patient Groups to Reduce Deficiency
Supplementing Vitamin D in Different Patient Groups to Reduce Deficiency
Pludowski et al., 2023 | Nutrients | Systematic Review
Citation
Pludowski Pawel. Supplementing Vitamin D in Different Patient Groups to Reduce Deficiency. Nutrients. 2023-Aug-25;15(17). doi:10.3390/nu15173725
Abstract
INTRODUCTION: Studies indicate a high prevalence of vitamin D deficiency in both the general population and at-risk groups. Given the association between vitamin D deficiency and various diseases, addressing this concern becomes crucial, especially in situations where routine monitoring is challenging. MATERIALS AND METHODS: A systematic literature review of the current knowledge on vitamin D dosing in diverse at-risk populations and the application of the findings to a broader clinical perspective. RESULTS: The reviewed studies revealed a high prevalence of vitamin D deficiency among patients with musculoskeletal disorders, systemic connective tissue diseases, corticosteroid use, endocrine and metabolic conditions, malabsorption syndromes, obesity, chronic kidney disease, cancer, and central nervous system diseases. Vitamin D deficiency was often more severe compared to the general population. Higher dosages of vitamin D beyond the recommended levels for the general population were shown to be effective in improving vitamin D status in these at-risk individuals. Additionally, some studies suggested a potential link between intermittent vitamin D administration and improved adherence. CONCLUSION: Simplified dosing could empower clinicians to address vitamin D deficiency, particularly in high-risk populations, even without routine monitoring. Further research is needed to establish the optimal dosing regimens for specific at-risk populations.
Key Findings
The reviewed studies revealed a high prevalence of vitamin D deficiency among patients with musculoskeletal disorders, systemic connective tissue diseases, corticosteroid use, endocrine and metabolic conditions, malabsorption syndromes, obesity, chronic kidney disease, cancer, and central nervous system diseases. Vitamin D deficiency was often more severe compared to the general population. Higher dosages of vitamin D beyond the recommended levels for the general population were shown to be effe
Outcomes Measured
- Requires manual extraction
Population
| Field | Value |
|---|---|
| Population | musculoskeletal disorders |
| Sample Size | See abstract |
| Age Range | See abstract |
| Condition | deficiency |
MeSH Terms
- Humans
- Vitamin D
- Vitamins
- Vitamin D Deficiency
- Knowledge
- Malabsorption Syndromes
Evidence Classification
- Level: Systematic Review
- Publication Types: Systematic Review, Journal Article
- Vertical: vitamin-d
Provenance
- PMID: 37686757
- DOI: 10.3390/nu15173725
- PMCID: PMC10489803
- Verified: 2026-04-09 via PubMed E-utilities API
Source extracted via PubMed E-utilities API on 2026-04-09